
#PutPeopleFirst
Gilead Sciences wants you to believe they are a benevolent organization working to help people. They say they have bold ambitions to create a healthier world for everyone. In reality, Gilead’s bold ambitions are more focused on creating wealth for their executives and shareholders.
Price gouging, withholding of safer HIV medicines, and slashing patient assistance programs – this is the real Gilead. Gilead is making billions of dollars in profits off taxpayer-subsidized research for many of the prescription drugs they sell. Gilead doesn’t put people first – unless they are shareholders.
It’s Time to Put an End To Corporate Greed
Get The Facts

Gilead Must Commit to Immediately and Broadly License Lenacapavir to the MPP and ViiV Must Take Steps to Expand and Unshroud its MPP License on Dolutegravir

Gilead’s ESG Awards Are Worthless. What About Drug Prices?

Federal court rejects drugmaker’s efforts to end lawsuit claiming they delayed more effective HIV treatment for more expensive, less effective drug
AIDS Advocates Lead the Way

